The Europe platelet rich plasma tube market is expected to grow from US$ 228.52 million in 2022 to US$ 575.84 million by 2028. It is estimated to grow at a CAGR of 16.7% from 2022 to 2028.
Increasing Cases of Sports Injuries Drive Growth of Europe Platelet Rich Plasma Tube Market
A surge in participation in sports activities leads to associated sports injuries. PRP injections can help stimulate the healing of injured athletes who underwent a minimally invasive procedure. A PRP treatment is performed by collecting the patient's blood, followed by the separation of plasma from the blood cells via a centrifugation process. The isolated plasma is injected into the injured area. The higher level of plasma harvested in the injection comprises growth factors that stimulate faster healing and recovery of the injury. PRP injections have become popular in treating tendon, muscle, and ligament injuries. According to a report published by the National Library of Medicine in 2021, there has been an increase in injury rates among soccer players in recent years. This high incidence of sport-related injury is often attributed to sports specialization and intense practice sessions at an early age. According to a report published by Statista Research Department in 2022, the most frequent injuries were reported among skiers in France in 2020. The lower limbs are at high risk of injury for skiers, with more than 50% of injuries recorded on the legs and knees during 2019–2020. Therefore, the rising incidence of sports injuries triggers the demand for PRP therapy among athletes, which is driving the growth of the platelet-rich plasma (PRP) tube market in Europe.
Europe Platelet Rich Plasma Tube Market Overview
Germany is among the top countries in the field of aesthetic medicine. According to the International Society of Aesthetic Plastic Surgery (ISAPS), it ranks fourth for performing a very high number of aesthetic procedures globally. In 2018, the total number of aesthetic procedures performed in the country was 922,056, accounting for ~4.0% of the total procedures across the world. In addition, a rise in the aging population is likely to result in a higher number of aesthetic procedures, as the loosening of skin is most common in this population. Per aarpinternational.org, Germany is one of five “super-aged” societies across the world. By 2050, one-third of its population will be of age 65 or more. Thus, an increasing in the cases of aesthetic procedures performed in Germany contributes to the demand for platelet rich plasma tubes.
Europe Platelet Rich Plasma Tube Market Segmentation
The Europe platelet rich plasma tube market is segmented on the basis of usage, volume, end user, and country.
Based on usage, the Europe platelet rich plasma tube market is segmented into skin rejuvenation, hair restoration, orthopedics, surgical oncology, gynecology, and others. In 2022, the others segment accounted for the largest market share. The skin rejuvenation segment is further subsegmented into scars, skin aging, acne, skin ulcers, and others.
By volume, the Europe platelet rich plasma tube market is segmented into less than 5 ml, 6 ml to 10 ml, and more than 10 ml. In 2022, the more than 10 ml segment accounted for the largest market share.
The Europe platelet rich plasma tube market, in terms of end user, is segmented into MedSpas, dermatology offices, hospitals and healthcare practices, tricologist practices, and others. In 2022, the hospitals and healthcare practice segment held the largest share of the market.
Based on country, the Europe platelet rich plasma tube market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. In 2022, the Rest of Europe segment registered a largest share in the Europe platelet rich plasma tube market.
ADVIN HEALTH CARE; BIO-X; Henso Medical (Hangzhou) Co Ltd; Lingen Precision Medical Products Co Ltd; and Manso Medical Co Ltd are the leading companies operating in the Europe platelet rich plasma tube market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 228.52 Million |
| Market Size by 2028 | US$ 575.84 Million |
| CAGR (2022 - 2028) | 16.7% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Usage
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
The Europe Platelet Rich Plasma Tube Market is valued at US$ 228.52 Million in 2022, it is projected to reach US$ 575.84 Million by 2028.
As per our report Europe Platelet Rich Plasma Tube Market, the market size is valued at US$ 228.52 Million in 2022, projecting it to reach US$ 575.84 Million by 2028. This translates to a CAGR of approximately 16.7% during the forecast period.
The Europe Platelet Rich Plasma Tube Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Platelet Rich Plasma Tube Market report:
The Europe Platelet Rich Plasma Tube Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Platelet Rich Plasma Tube Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Platelet Rich Plasma Tube Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Platelet Rich Plasma Tube Market
